IPCALAB / NSE / Biotechnology & Drugs
IPCA Laboratories
1Y Price Trend
Key Information
Recommendations
RatingStrong Buy
Target High1,679.45
Target Low1,252.95
Target Mean1.64
Target Median80.36
Risk Metrics
Overall RiskBalanced risk
Board Risk26.4
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Freshers Walk-In Interview 2026 :Multiple Openings at Ipca Laboratories BioTecNika
Ipca Laboratories Ltd gains for third straight session Business Standard
Broad-Based Technical Strength Lifts Ipca Laboratories Ltd to 52-Week High of Rs 1662 Markets Mojo
Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant Indian Pharma Post
Ipca Laboratories Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals Markets Mojo
Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals Markets Mojo
Ipca Laboratories Ltd stock (INE571A01038): shares edge higher on Indian market amid steady pharma m AD HOC NEWS
MarketsMOJO Upgrades Ipca Laboratories Ltd to Buy on Strong Technical and Financial Performance Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026

